Key points are not available for this paper at this time.
Design
Editorial
This editorial highlights the need to further elucidate the role of CRP as a predictor of vascular risk and the clinical relevance of CRP-lowering agents.
This editorial discusses whether measuring C-reactive protein (CRP) levels can be used as a predictor of vascular risk. The agents that reduce CRP levels and the evidence for a possible causative role of CRP in the pathogenesis of coronary events and atherosclerosis are also considered. There is a need to further elucidate the role of CRP, as well as the clinical relevance, if any, of CRP-lowering agents.
No takes yet. Share an insight, caveat, or question.
Paraskevas et al. (2007) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: